search.noResults

search.searching

saml.title
dataCollection.invalidEmail
note.createNoteMessage

search.noResults

search.searching

orderForm.title

orderForm.productCode
orderForm.description
orderForm.quantity
orderForm.itemPrice
orderForm.price
orderForm.totalPrice
orderForm.deliveryDetails.billingAddress
orderForm.deliveryDetails.deliveryAddress
orderForm.noItems
Sponsored by News


New Cancer Taskforce launched to save lives and improve services for children and young people


Clinicians, charities, patient groups and the government are on a joint mission to combat childhood cancer through a new taskforce. The Children and Young People Cancer Taskforce, to be chaired by Dame Caroline Dinenage MP, aims to improve how we detect, treat and care for children with cancer, and will discuss how to save lives and deliver world-leading cancer services. While rare, cancer is the leading cause of death


in children aged 1 to 14 and one of the biggest causes of death in young people in the UK. More children are surviving than ever before, but the long-term impacts can remain significant. The taskforce presents an opportunity to act and will consider genomic treatments, new diagnosis tools, research and innovation. Health and Social Care Secretary, Victoria Atkins, said: “Discovering your child has cancer is among the worst news a parent can receive. Thanks to the remarkable progress in treatment and research, survival rates are higher than ever. However, even then, life-changing consequences can remain. “This taskforce will help bring together world- leading experts and those who have dedicated their lives to fighting cancer to discuss how we can go further faster and to drive progress in cancer care for children and young people.” Tireless campaigner on childhood cancer,


Dame Caroline Dinenage will bring her knowledge, dedication, as well as her experience as a Parliamentarian, to her role as chair. Under her


leadership, the taskforce’s areas of focus will include: l DNA testing and treatment - ensuring children and young people get access to high-quality personalised therapies, new treatments and personalised medicines are more readily available, and the offer in the devolved administrations is examined.


l Detection and diagnosis - giving children the best chance to beat cancer through earlier diagnosis, improving training, exploring how artificial intelligence can further support the workforce and raising awareness so people come forward sooner.


New CALEX Faecal Calprotectin


Sample Collection Kits Enable patients to efficiently prepare and send in their samples, ready for calprotectin testing, freeing up valuable resources in the laboratory.


Streamlined Workflow


3Immediate calprotectin stabilisation for 7 days at ambient


3Samples arrive ready for analysing


3Survey has demonstrated high acceptance and ease of use for patients


3Good correlation with lab prepared samples Join the continued CALEX Workflow Revolution


Optimise, Simplify, and Elevate Your Laboratory Processes! alphalabs.co.uk/calex-pack


Phone: 023 8048 3000 Email: sales@alphalabs.co.uk


01 CALEX Patient Packs - CSJ - 180x94 - March 2024.indd 1 13/02/2024 14:47:22 March 2024 I www.clinicalservicesjournal.com 13


l Investment in research and innovation - improving the targeting of research funding, reviewing children’s access to clinical trials, gaining greater access to data (including potential data-sharing arrangements with Australia) to inform future therapies and treatments in England, and encouraging teams to consider innovative solutions.


Structured meetings to drive forward progress will be held with a mix of experts and senior figures from the Department of Health and Social Care, NHS England and the Office for Life Sciences, as well as appointees from the wider clinical community.


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68